Submitted by Anonymous (not verified) on 27 September 2023 - 13:45
Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Diabetes Mellitus, Type 2, Date of authorisation: 27/05/2015, Revision: 26, Status: Authorised
Source: